InTrack Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

InTrack Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,831	Closed	-$370K	–	133
2024 Q1	$370K	Buy	6,831 +166	+2%	+$8.46K	0.27%	103
2023 Q4	$342K	Sell	6,665 -9,720	-59%	-$510K	0.26%	106
2023 Q3	$951K	Buy	16,385 +2,924	+22%	+$179K	0.84%	33
2023 Q2	$861K	Sell	13,461 -1,166	-8%	-$78.2K	0.7%	49
2023 Q1	$1.01M	Buy	14,627 +1,660	+13%	+$117K	0.92%	32
2022 Q4	$933K	Sell	12,967 -5,187	-29%	-$391K	0.93%	35
2022 Q3	$1.29M	Buy	18,154 +5,339	+42%	+$387K	1.43%	19
2022 Q2	$987K	Sell	12,815 -3,002	-19%	-$229K	1.01%	33
2022 Q1	$1.16M	Sell	15,817 -962	-6%	-$64.6K	0.94%	36
2021 Q4	$1.05M	Buy	16,779 +2,240	+15%	+$131K	0.72%	52
2021 Q3	$853K	Buy	14,539 +10,319	+245%	+$680K	0.62%	62
2021 Q2	$281K	Sell	4,220 -280	-6%	-$18.3K	0.22%	99
2021 Q1	$284K	Buy	+4,500	New	+$280K	0.26%	87

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

InTrack Investment Management's BMY Position: Q2 2024 in Review

InTrack Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 6,831 shares — an estimated $370K sold.

InTrack Investment Management first reported a position in BMY in Q1 2021 and held it in 13 quarters. The position peaked at $1.29M in Q3 2022. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

InTrack Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
InTrack Investment Management sold 6,831 Bristol-Myers Squibb shares in Q2 2024, an estimated $370K.
InTrack Investment Management first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 13 quarters.
InTrack Investment Management's Bristol-Myers Squibb position peaked at $1.29M in Q3 2022.
2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on InTrack Investment Management's 13F filing for Q2 2024, filed 15 Jul 2024.